微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 12.39% | 14.72% | 42.58% | 14/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 8.69% | 24.5% | 136.14% | 13/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.68% | 3.66% | -68.55% | 20/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 11.7% | 6.85% | 8.33% | 22/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 10.8% | 10.88% | 54.73% | 21/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 6.98% | 2.2% | 96.62% | 20/158 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.55% | 7.58% | -67.58% | 25/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 10.95% | 19.93% | 12.42% | 41/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 9.74% | 5.18% | 42.61% | 31/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.83% | 16.55% | 106.97% | 27/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.3% | 8.91% | -63.86% | 31/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 9.13% | -15.54% | -1.4% | 47/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 9.26% | -5.61% | 58.02% | 39/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.86% | -1.84% | 93.4% | 41/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.03% | -3.81% | -71.97% | 43/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.81% | -11.18% | 10.19% | 47/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 9.81% | -12.72% | 64.32% | 38/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.97% | -16.03% | 89.52% | 44/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 3.15% | -23.36% | -74.12% | 32/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 12.17% | 1.76% | 8.27% | 41/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 11.24% | 2.27% | 58.09% | 27/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 7.11% | -1.8% | 72.99% | 30/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.11% | 4.05% | -65.64% | 19/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 11.96% | 3.55% | 8.83% | 41/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 10.99% | 6.7% | 51.8% | 20/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.24% | -0.14% | 83.29% | 21/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.95% | 14.49% | -65.8% | 17/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 11.55% | 12.03% | 12.14% | 42/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 10.3% | 9.69% | 42.07% | 25/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 7.25% | 13.28% | 110.14% | 27/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.45% | 17.35% | -66.54% | 19/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 10.31% | 47.92% | 9.8% | 55/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 9.39% | 5.98% | 46.72% | 27/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 6.4% | 20.3% | 117.69% | 32/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.94% | -8.13% | -57.82% | 29/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 6.97% | -26.79% | -21.33% | 62/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 8.86% | 12.72% | 66.54% | 31/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 5.32% | -5% | 66.25% | 35/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 3.2% | 15.11% | -66.39% | 26/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | 9.52% | -23.78% | 21.12% | 53/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 7.86% | -25.64% | 40.36% | 29/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 5.6% | -16.91% | 101.44% | 21/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 2.78% | -12.03% | -77.74% | 21/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |